Bilateral breast myxedema caused by Graves' disease and responsive to multipoint subcutaneous injection of long-acting glucocorticoid : Case report
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc..
RATIONALE: With the absence of ophthalmopathy, thyroid dermopathy especially lesions at atypical locations is a very rare presentation. We herein report an original case of bilateral breast myxedema caused by Grave's disease.
PATIENT CONCERNS: A 21-year-old unmarried woman presented with a 4-month history of Grave's disease and a 1-month history of progressive bilateral breast enlargement. She had symmetrical bilateral breast enlargement with redness and nonpitting thickening of the skin, diffusely enlarged thyroid glands, and no exophthalmos.
DIAGNOSIS: Ultrasonography, magnetic resonance imaging scan, and skin biopsy confirmed the diagnosis of bilateral breast myxedema.
INTERVENTIONS: The patient was treated with multipoint subcutaneous injections of triamcinolone acetonide in each breast every month.
OUTCOMES: The bilateral breast returned approximately to its normal size after therapy for 6 months.
CONCLUSIONS: Our case illustrates that multipoint subcutaneous injection of glucocorticoids is beneficial for bilateral breast myxedema.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:100 |
---|---|
Enthalten in: |
Medicine - 100(2021), 25 vom: 25. Juni, Seite e26469 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Du, Tingting [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 29.06.2021 Date Revised 03.01.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1097/MD.0000000000026469 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM327077549 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM327077549 | ||
003 | DE-627 | ||
005 | 20231225195957.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1097/MD.0000000000026469 |2 doi | |
028 | 5 | 2 | |a pubmed24n1090.xml |
035 | |a (DE-627)NLM327077549 | ||
035 | |a (NLM)34160454 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Du, Tingting |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bilateral breast myxedema caused by Graves' disease and responsive to multipoint subcutaneous injection of long-acting glucocorticoid |b Case report |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 29.06.2021 | ||
500 | |a Date Revised 03.01.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. | ||
520 | |a RATIONALE: With the absence of ophthalmopathy, thyroid dermopathy especially lesions at atypical locations is a very rare presentation. We herein report an original case of bilateral breast myxedema caused by Grave's disease | ||
520 | |a PATIENT CONCERNS: A 21-year-old unmarried woman presented with a 4-month history of Grave's disease and a 1-month history of progressive bilateral breast enlargement. She had symmetrical bilateral breast enlargement with redness and nonpitting thickening of the skin, diffusely enlarged thyroid glands, and no exophthalmos | ||
520 | |a DIAGNOSIS: Ultrasonography, magnetic resonance imaging scan, and skin biopsy confirmed the diagnosis of bilateral breast myxedema | ||
520 | |a INTERVENTIONS: The patient was treated with multipoint subcutaneous injections of triamcinolone acetonide in each breast every month | ||
520 | |a OUTCOMES: The bilateral breast returned approximately to its normal size after therapy for 6 months | ||
520 | |a CONCLUSIONS: Our case illustrates that multipoint subcutaneous injection of glucocorticoids is beneficial for bilateral breast myxedema | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Triamcinolone Acetonide |2 NLM | |
650 | 7 | |a F446C597KA |2 NLM | |
700 | 1 | |a Jiang, Wangyan |e verfasserin |4 aut | |
700 | 1 | |a Luo, Hongchang |e verfasserin |4 aut | |
700 | 1 | |a Chen, Fuqiong |e verfasserin |4 aut | |
700 | 1 | |a Yuan, Gang |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Muxun |e verfasserin |4 aut | |
700 | 1 | |a Liu, Zhelong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicine |d 1945 |g 100(2021), 25 vom: 25. Juni, Seite e26469 |w (DE-627)NLM000020737 |x 1536-5964 |7 nnns |
773 | 1 | 8 | |g volume:100 |g year:2021 |g number:25 |g day:25 |g month:06 |g pages:e26469 |
856 | 4 | 0 | |u http://dx.doi.org/10.1097/MD.0000000000026469 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 100 |j 2021 |e 25 |b 25 |c 06 |h e26469 |